Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Orphan Medical obtains European marketing rights for Colomed

May 24, 1996

5-HT4 antagonist LY-353433: Potential treatment for GI disorders

May 24, 1996

Lexirin cleared to enter phase I

May 17, 1996

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Tobishi reports outstanding selectivity of it's CCK-A antagonist

May 10, 1996

James Black Foundation describes CCK-B/gastrin receptor antagonist

May 10, 1996

Plasmin/kallikrein inhibitors from Hisamitsu

May 3, 1996

Hepagene preliminary phase III results look positive

May 3, 1996

Somatix hepatitis therapy receives patent coverage

May 3, 1996

Dainippon reports anti-H. pylori compounds

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...